Myriad Genetics Inc banner

Wall St Price Targets

MYGN Price Forecast
Based on 10 analysts

-26% Downside
from $6.365 today

Myriad Genetics Inc (MYGN)’s 12-month stock price forecast through October 2027 has a consensus target of $4.692, implying 26% downside. The forecast is based on price targets from 10 Wall Street analysts.

MYGN Analyst Rating
Based on 9 analysts

avg. 2.89 of 5
Strong buy
1 11%
Buy
0 0%
Hold
6 67%
Sell
1 11%
Strong sell
1 11%

Analysts rate MYGN Hold, with 6 of 9 recommending Hold.

Myriad Genetics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MYGN's stock price target?
Price Target
4.692 USD

According to Wall Street analysts, the average 1-year price target for MYGN is 4.692 USD with a low forecast of 2.525 USD and a high forecast of 8.4 USD.

What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
4%

Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 4%.

What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
4%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 4%.

Back to Top